Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tango Therapeutics Inc.

6.53
+0.49008.11%
Post-market: 6.660.1300+1.99%19:19 EDT
Volume:5.24M
Turnover:33.52M
Market Cap:707.81M
PE:-5.42
High:6.82
Open:5.77
Low:5.77
Close:6.04
Loading ...

Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Yesterday

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

GlobeNewswire
·
22 Jul

Tango Therapeutics Inc. Unveils New Strategies in Targeted Oncology Therapies with Promising Clinical Updates

Reuters
·
01 Jul

Tango Therapeutics Shares Climb After First Patient Dosed in Pancreatic, Lung Cancer Trial

Dow Jones
·
27 Jun

BRIEF-Tango Therapeutics Announces First Patient Dosed In Phase 1/2 Trial Of Tng462 Plus Revolution Medicines’ Daraxonrasib

Reuters
·
27 Jun

Barbara Weber Resigns from Revolution Medicines Inc. Board Ahead of 2025 Stockholders Meeting

Reuters
·
19 Jun

Tango Therapeutics (TNGX) Receives a Buy from Barclays

TIPRANKS
·
09 Jun

Tango Therapeutics Inc. Conducted Annual Stockholders' Meeting

Reuters
·
07 Jun

Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer

MT Newswires Live
·
21 May

BRIEF-Tango Therapeutics Files For Mixed Shelf Of Up To $400 Million

Reuters
·
13 May

Tango Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May

Tango Therapeutics Q1 EPS $(0.36) Misses $(0.35) Estimate, Sales $5.39M Miss $6.69M Estimate

Benzinga
·
12 May

Press Release: Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Dow Jones
·
12 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
10 May

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
05 May

Tango Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
02 May

Press Release: Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Dow Jones
·
01 May

Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)

TIPRANKS
·
16 Apr

Tango Therapeutics Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Apr